Bharat Biotech vaccine candidate approved for use in clinical trial mode. The first COVID-19 vaccine developed in India, Covaxin, has been recommended for “restricted use in emergency situations, subject to multiple regulatory conditions” by the Subject Matter Expert Committee (SEC) of the Central Medicines Control Organization ( CDSCO), here on …
Read More »
Covaxin has been indigenously developed in collaboration with ICMR. An expert panel from India’s central drug authority recommended on January 2 to grant permission for the emergency restricted use of the locally developed COVID-19 vaccine Covaxin with certain conditions, a day after giving similar instructions for the COVID vaccine. -19 …
Read More »
The Brihanmumbai Municipal Corporation (BMC) has completed the second phase of clinical trials for the Oxford-AstraZeneca Covid-19 vaccine. The civic body will soon begin testing for the third phase after the first group of volunteers completes 28 days from their first vaccination. 200 healthy volunteers participated in the second phase …
Read More »